07/22/2025
🧠Why do board-certified pathologists matter in preclinical research?
Accurate, expert tissue interpretation isn't just for diagnostics — it's a cornerstone of credible, reproducible R&D.
At iHisto, our team of MD (ABP) and DVM (ACVP) pathologists provides research-use-only reviews and pathology reporting for toxicology, biomarker validation, and drug discovery.
🔬 See how pathology expertise improves data quality, reduces regulatory risk, and speeds up your IND path.
📖 Read the full blog:
👉 https://www.ihisto.io/post/board-certified-pathologist-report
In preclinical studies, the accuracy of pathology interpretation can make or break a program. Whether you're evaluating a compound's safety, validating a biomarker, or preparing for regulatory submission, expert tissue evaluation is non-negotiable. That’s where board-certified pathologists—MDs (...